Data Set PubMed ID Cancer Type Array Type Groups (Number of Samples) Number of Probes Number of Regions CGHpower
Chin et al. 17925008 breast spotted oligo ER+ (113) vs. ER- (57) 26,755 223 Output
Douglas et al. 15256451 colorectal BAC MSI (7) vs. CIN (30) 3,032 142 Output
Fridlyand et al. 16620391 breast BAC TP53+ (10) vs. TP53- (52) 1,877 231 Output
Myllykangas et al. 18506690 gastric cDNA diffuse (15) vs. intestinal (23) 11,342 260 Output
Nymark et al. 16740712 lung cDNA asbestos-exposed (11) vs. non-exposed (9) 10,953 242 Output
Postma et al. 19150955 colorectal spotted oligo good (16) vs. bad response (16) 26,755 111 Output
Smeets et al. 16314836 head and neck BAC HPV+ (12) vs. HPV- (12) 4,196 143 Output
Wrage et al. 19208797 lung spotted oligo BM+ (13) vs. BM- (15) 25,549 23 Output
Simulation 0     in-situ oligo (15) vs. (15) 42,331 440 Output
Simulation 1     in-situ oligo (15) vs. (15) 42,331 462 Output
Simulation 2     in-situ oligo (15) vs. (15) 42,331 457 Output
Simulation 3     in-situ oligo (15) vs. (15) 42,331 461 Output
Simulation 4     in-situ oligo (15) vs. (15) 42,331 492 Output
Simulation 5     in-situ oligo (15) vs. (15) 42,331 489 Output
Simulation 6     in-situ oligo (15) vs. (15) 42,331 501 Output
Simulation 7     in-situ oligo (15) vs. (15) 42,331 501 Output
Simulation 8     in-situ oligo (15) vs. (15) 42,331 490 Output
Simulation 9     in-situ oligo (15) vs. (15) 42,331 507 Output
Simulation 10     in-situ oligo (15) vs. (15) 42,331 525 Output
ER = estrogen receptor, MSI = microsatellite instability, CIN = chromosomal instability, HPV = human papilloma virus, BM = bone marrow metastasis